Prof Paul Maruff
Honorary Principal Fellow
Florey Department of Neuroscience and Mental Health
900 Scholarly works
10 Projects
HIGHLIGHTS
2026
Journal article
Genetic drivers of progression in Alzheimer’s disease are distinct from disease risk
DOI: 10.1186/s13195-026-02036-12026
Journal article
The impact of pyruvate kinase deficiency on cognition
DOI: 10.1016/j.brci.2026.1000942025
Research grants (ARC, NHMRC, MRFF)
Optimising the Therapeutic Value of Cholinesterase Inhibitors in Alzheimer’s Disease
2023
Research grants (ARC, NHMRC, MRFF)
An Integrated Method for the Assessment and Monitoring of Dementia and Cognitive Impairment: The Cognition - Optimised, Digitised, and Harmonised (C-Odh) Platform
2021
Research Grant
The Effect of Hearing Aid Use Hearing Loss on Cognitive Function in Older Adults With Hearing Loss.
2016
Journal article
Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease
DOI: 10.1016/j.jalz.2015.12.0132015
Journal article
Phenomenological characterization of memory complaints in preclinical and prodromal alzheimer's disease
DOI: 10.1037/neu0000156
RECENT SCHOLARLY WORKS
2026
Journal article
Exploring the relationship between methylation of the cortisol receptor genes and brain and cognitive outcomes in individuals with elevated amyloid-β
DOI: 10.1038/s41398-026-04310-02026
Journal article
Peripheral DNA methylation of candidate Alzheimer’s disease risk genes and its associations with cognition, brain volume and amyloid-β burden
DOI: 10.1038/s41598-026-64935-52026
Journal article
Pilot feasibility, acceptability, and tolerability of researcher-delivered apolipoprotein E (APOE) disclosure via videoconferencing in Australian adults at-risk of dementia
DOI: 10.1177/138728772614590682026
Journal article
Remote, self-administered, smartphone cognitive testing in a registry-based cohort: Feasibility, reliability, and validity findings
DOI: 10.1002/alz.715802026
Journal article
Evidence for direct and sleep-moderated relationships between aquaporin-4 genetic variants and Alzheimer's disease phenotypes
DOI: 10.1002/alz.715162026
Journal article
0738 Oveporexton (TAK-861) Improves Cognitive Symptoms in Patients with Narcolepsy Type 1: Results from Two Randomized, Placebo-controlled Phase 3 Trials
DOI: 10.1093/sleep/zsag091.07372026
Journal article
0726 Clinical Meaningfulness of Cognitive Improvements with Oveporexton (TAK-861) in Adults with Narcolepsy Type 1 (NT1)
DOI: 10.1093/sleep/zsag091.07252026
Journal article
Composite scores to detect and monitor cognitive dysfunction in preclinical and prodromal Alzheimer's disease: A narrative review
DOI: 10.1177/13872877261433044